Publication: Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
dc.contributor.coauthor | Etzion, Ohad | |
dc.contributor.coauthor | Hamid, Saeed Sadiq | |
dc.contributor.coauthor | Asselah, Tarik | |
dc.contributor.coauthor | Gherlan, George Sebastian | |
dc.contributor.coauthor | Turcanu, Adela | |
dc.contributor.coauthor | Petrivna, Tsarynna | |
dc.contributor.coauthor | Weissfeld, Lisa | |
dc.contributor.coauthor | Choong, Ingrid | |
dc.contributor.coauthor | Hislop, Colin | |
dc.contributor.coauthor | Apelian, David | |
dc.contributor.coauthor | Buti, Maria | |
dc.contributor.coauthor | Gheorghe, Liana | |
dc.contributor.coauthor | Iliescu, Elena Laura | |
dc.contributor.coauthor | Voronkova, Natalia | |
dc.contributor.coauthor | Barsukova, Natalia | |
dc.contributor.coauthor | Aleman, Soo | |
dc.contributor.coauthor | Feld, Jordan J. | |
dc.contributor.coauthor | Reau, Nancy S. | |
dc.contributor.coauthor | Brunetto, Maurizia | |
dc.contributor.coauthor | Lampertico, Pietro | |
dc.contributor.coauthor | Heller, Theo | |
dc.contributor.coauthor | Koh, Chris | |
dc.contributor.coauthor | Glenn, Jeffrey | |
dc.contributor.department | KUH (Koç University Hospital) | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Yurdaydın, Cihan | |
dc.contributor.schoolcollegeinstitute | KUH (KOÇ UNIVERSITY HOSPITAL) | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-12-29T09:38:31Z | |
dc.date.issued | 2023 | |
dc.description.indexedby | WOS | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.volume | 78 | |
dc.identifier.eissn | 1600-0641 | |
dc.identifier.issn | 0168-8278 | |
dc.identifier.quartile | Q1 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/22697 | |
dc.identifier.wos | 1037135100013 | |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartof | Journal of Hepatology | |
dc.subject | Gastroenterology and hepatology | |
dc.title | Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Yurdaydın, Cihan | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit1 | KUH (KOÇ UNIVERSITY HOSPITAL) | |
local.publication.orgunit2 | KUH (Koç University Hospital) | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
relation.isParentOrgUnitOfPublication | 055775c9-9efe-43ec-814f-f6d771fa6dee | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 055775c9-9efe-43ec-814f-f6d771fa6dee |